First Read: Ipsen SA "Positive P3 ELSPIRE study for Iqirvo in PBC" (Neutral)

研报英文原文证据摘录

First Read: Ipsen SA "Positive P3 ELSPIRE study for Iqirvo in PBC" (Neutral)

ly affect the value, price or income of any security or related instrument referred to in the document.

For investment advice, trade execution or other enquiries, clients should contact their local sales representative.

UBS notes that no globally accepted framework or definition (legal, regulatory or otherwise) currently exists, nor is there a market consensus as to what

constitutes an “ESG” (Environmental, Social or Governance) or an equivalent-label, or as to what precise attributes are required for the Information (as defined

below) to be defined as ESG or equivalently-labelled. Any information, data or other content including from a third party source contained, referred to herein or

used for whatsoever purpose by UBS or a third party (“Information”), in relation to any actual or potential ESG objective, issue or consideration is not intended to

be relied upon for ESG classification, regulatory regime or industry initiative purposes (“ESG Regimes”). Nothing in these materials is intended to convey, suggest

or indicate that UBS considers or represents any product, service, person or body mentioned in these materials as meeting or qualifying for any ESG classification,

labelling or similar standards that may exist under the ESG Regimes. UBS has not conducted any assessment of compliance with ESG Regimes. Parties are

reminded to make their own assessments for these purposes.

The value of any investment or income may go down as well as up, and investors may not get back the full (or any) amount invested. Past performance is not

necessarily a guide to future performance. Neither UBS nor any of its directors, employees or agents accepts any liability for any loss (including investment loss) or